Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Revisiting Hepatitis B virus: Challenges of curative therapies
Jianming Hu
, Ulrike Protzer
, Aleem Siddiqui
Penn State Cancer Institute
Cancer Institute, Mechanisms of Carcinogenesis
Department of Cell and Biological Systems
Research output
:
Contribution to journal
›
Review article
›
peer-review
113
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Revisiting Hepatitis B virus: Challenges of curative therapies'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hepatitis B Virus
100%
Virus Challenge
100%
Curative Treatment
100%
Covalently Closed Circular DNA
66%
Viral
22%
Hepatocytes
22%
Virus
11%
Health Problems
11%
Gene Products
11%
Viral Genome
11%
Virus Capsid
11%
Viral Gene
11%
Fibrosis
11%
Reverse Transcriptase
11%
Viral Replication
11%
Pregenomic RNA (pgRNA)
11%
Host Cell
11%
Antiretroviral Therapy
11%
Relaxed Circular DNA
11%
Hepatitis B Virus Infection
11%
Virus Persistence
11%
Therapeutic Target
11%
Virus Life Cycle
11%
Cell nucleus
11%
Therapeutic Potential
11%
Hepatocellular Carcinoma
11%
Host Immune Response
11%
Cirrhosis
11%
Host Genome
11%
DNA Genome
11%
DNA Virus
11%
Reverse Transcriptase Activity
11%
Prophylactic Vaccine
11%
Minichromosome
11%
Chronic Hepatitis
11%
Death Toll
11%
Antiviral Immune Response
11%
Curative Strategies
11%
Medicine and Dentistry
Hepatitis B Virus
100%
Circular DNA
77%
RNA Directed DNA Polymerase
22%
Hepatocyte
22%
Antiviral Drug
22%
Fibrosis
11%
DNA Template
11%
Virus Capsid
11%
Host Cell
11%
Cell Nucleus
11%
Hepatocellular Carcinoma
11%
Virus Replication
11%
Life Cycle
11%
Virus DNA
11%
Immune Response
11%
Liver Cirrhosis
11%
Virus Genome
11%
Hepatitis B
11%
Gene Product
11%
Antiviral Therapy
11%
Chronic Hepatitis
11%
Persistent Virus Infection
11%
Antiviral Immune Response
11%
Diseases
11%
Virus
11%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis B Virus
100%
Circular DNA
77%
RNA Directed DNA Polymerase
22%
Antiviral Drug
22%
Elimination
11%
Fibrosis
11%
Liver Cell Carcinoma
11%
Antivirus Agent
11%
Liver Cirrhosis
11%
Antiviral Therapy
11%
Hepatitis B
11%
Virus DNA
11%
Chronic Hepatitis
11%
Diseases
11%
Immunology and Microbiology
Hepatitis B Virus
100%
Reverse Transcriptase
22%
Gene Product
11%
Viral Replication
11%
Virus Genome
11%
Life Cycle
11%
Capsid
11%
DNA Template
11%
Host Cell
11%
Hepatitis B
11%
Host Immune Response
11%
Cell Nucleus
11%
Antiviral Immune Response
11%
DNA Virus
11%
Virus
11%
Biochemistry, Genetics and Molecular Biology
Hepatitis B Virus
100%
RNA
20%
Reverse Transcriptase
20%
Hepatocyte
20%
Immune Response
20%
DNA Template
10%
Virus Genome
10%
Virus Replication
10%
Capsid
10%
Gene Product
10%
Life Cycle
10%
Minichromosome
10%
DNA Virus
10%